Kensey Nash Corporation is a medical device company known for providing
innovative product development and advanced technology for a wide range of
medical procedures. The Company has expanded well beyond its beginnings in
vascular puncture closure and today, through its biomaterials and endovascular
business units provides an extensive range of products into multiple medical
markets.
As the inventor of the Angio-Seal™ Vascular Closure Device, now manufactured,
marketed and sold by St. Jude Medical Inc., Kensey Nash Corporation pioneered
the concept of arterial closure -- establishing itself as an innovative leader in
cardiovascular technology. That innovative ability enabled the Company to
expand its biomaterials technology and it now designs, develops and
manufactures biomaterials-based products which are commercially available in
the fields of orthopaedics (including sports medicine and spine), cardiology, drug
delivery, oral care, general surgery, trauma and wound care. These biomaterialbased
products include synthetic polymers, collagen, polysaccharides and
ceramics which are turned into novel products in the areas of soft and hard tissue
fixation, soft and hard tissue regeneration and biologic drug carriers which are
manufactured for and distributed by Fortune 100 companies and emerging new
technology companies alike.
Kensey Nash’s endovascular business currently manufactures, markets and sells
products that address the thrombus management and vascular occlusive
markets. The QuickCat™ Extraction Catheter removes soft, fresh thrombus. The
ThromCat™ Mechanical Thrombectomy Catheter System utilizes HeliFlex™ technology to flush, macerate and extract thrombus while the Safe-Cross™ Radio
Frequency Total Occlusion Crossing System utilizes guide wire technology to
cross and recanalize Chronic Total Occlusions (CTOs).
